Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: Comparative study with desipramine, fluvoxamine, venlafaxine and opiates

Journal of Psychopharmacology

Volumn 18, Issue 3, 2004, Pages 404-411

  Rojas Corrales, M Olga ^a   Berrocoso, Esther ^a   Gibert Rahola, Juan ^a   Micó, Juan Antonio ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Desipramine; Fluvoxamine; Levorphanol; Methadone; Morphine; Reserpine test; Tramadol; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUVOXAMINE; LEVORPHANOL; METHADONE; MORPHINE; OPIATE; RESERPINE; TRAMADOL; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENANTIOMER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PTOSIS; RECTUM TEMPERATURE;

ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; BLEPHAROPTOSIS; BODY TEMPERATURE; CYCLOHEXANOLS; DESIPRAMINE; FLUVOXAMINE; LEVORPHANOL; MALE; METHADONE; MICE; MORPHINE; NARCOTICS; RESERPINE; STEREOISOMERISM; TIME FACTORS; TRAMADOL;

EID: 6044238356     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110401800305     Document Type: Article

References (39)

1. Askew J S (1963) A simple screening procedure for imipramine-like antidepressant agents. Life Sci 10: 725-730
2. Bamigbade T A, Davidson C, Langford R M, Stamford J A (1997) Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. Br J Anaesth 79: 352-356
3. Besson A, Privat A M, Eschalier A, Fialip J (1996) Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats. Psychopharmacology (Berl) 123: 71-78
4. Bodkin J A, Zomberg G L, Lukas S E, Cole J O (1995) Buprenorphine treatment of refractory depression. J Clin Psychopharmacol 15: 49-57
5. Boureau F, Legallicier P, Kabir-Ahmadi M (2003) Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 104: 323-331
6. Bourin M, Poncelet M, Chermat R, Simon P (1983) The value of the reserpine test in psychopharmacology. Arzneimittelforschung 33: 1173-1176
7. Bunney W E Jr, Davis J M (1965) Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry 13: 483-494
8. Codd E E, Shank R P, Schupsky J J, Raffa R B (1995) Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther 274: 1263-1270
9. Friderichs E, Felgenhauer F, Jongschaap P, Osterloh G (1978) [Pharmacological studies on analgesia, dependence on and tolerance of tramadol, a potent analgetic drug]. Arzneimittelforschung 28: 122-134
10. Geyer M A, Markou A (1995) Animal models of psychiatric disorders. In Bloom F E, Kupfer D J (eds), Psychopharmacology: the fourth generation of progress, pp. 787-798. Raven Press, New York
11. Gold P W, Goodwin F K, Chrousos G P (1988) Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N Engl J Med 319: 348-353
12. Goodwin F K, Bunney W E Jr (1971) Depressions following reserpine: a reevaluation. Semin Psychiatry 3: 435-448
13. Halfpenny D M, Callado L F, Hopwood S E, Bamigbade T A, Langford R M, Stamford J A (1999) Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real time voltammetry. Br J Anaesth 83: 909-915
14. Hopwood S E, Owesson C A, Callado L F, McLaughlin D P, Stamford J A (2001) Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function. J Psychopharmacol 15: 147-153
15. Lepine J P, Goger J, Blashko C, Probst C, Moles M F, Kosolowski J, Scharfetter B, Lane R M (2000) A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. Int Clin Psychopharmacol 15: 263-271
16. Markowitz J S, Patrick K S (1998) Venlafaxine-tramadol similarities. Med Hypotheses 51: 167-168
17. Millan M J, Dekeyne A, Papp M, La Rochelle C D, MacSweeny C, Peglion J L, Brocco M (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298: 581-591
18. Ossipov M H, Malan TPJ, Lai J, Porreca F (1997) Opioid pharmacology of acute and chronic pain. In: Dickenson A, Besson J M (eds), Handbook of experimental pharmacology, pp. 305-327. Springer, Berlin
19. Pernia A, Mico J A, Calderon E, Torres L M (2000) Venlafaxine for the treatment of neuropathic pain. J Pain Sympt Manage 19: 408-410
20. Price D D (2000) Psychological and neural mechanisms of the affective dimension of pain. Science 288: 1769-1772
21. Raffa R B (1996) A novel approach to the pharmacology of analgesics. Am J Med 101: 40S-46S
22. Raffa R B, Friderichs E, Reimann W, Shank R P, Codd E E, Vaught J L (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 260: 275-285
23. Rojas-Corrales M O, Gibert-Rahola J, Mico J A (1998) Tramadol induces antidepressant-type effects in mice. Life Sci 63: L175-L180
24. Rojas-Corrales M O, Ortega-Alvaro A, Gibert-Rahola J, Roca-Vinardell A, Mico J A (2000) Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine (1A/1B) antagonist, enhances the analgesic effect of tramadol. Pain 88: 119-124
25. Rojas-Corrales M O, Berrocoso E, Gibert-Rahola J, Mico J A (2002) Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 72: 143-152
26. Rubin B, Mallone M, Vaugh M H, Burke J C (1957) Bioassay of rauwolfia roots and alkaloids. J Pharmacol 120: 125-136
27. Schnitzer T J, Gray W L, Paster R Z, Kamin M (2000) Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 27: 772-778
28. Schreiber S, Backer M M, Yanai J, Pick C G (1996) The antinociceptive effect of fluvoxamine. Eur Neuropsychopharmacol 6: 281-284
29. Schreiber S, Backer M M, Pick C G (1999) The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 273: 85-88
30. Shapira N A, Keck P E Jr, Goldsmith T D, McConville B J, Eis M, McElroy S L (1997) Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder. Depress Anxiety 6: 170-173
31. Shapira N A, Verduin M L, DeGraw J D (2001) Treatment of refractory major depression with tramadol monotherapy. J Clin Psychiatry 62: 205-206
32. Simpson F O, Waal-Manning H J (1971) Hypertension and depression: interrelated problems in therapy. J R Coll Physicians Lond 6: 14-24
33. Spencer C (2000) The efficacy of intramuscular tramadol as a rapid-onset antidepressant. Aust N Z J Psychiatry 34: 1032-1033
34. Stoll A L, Rueter S (1999) Treatment augmentation with opiates in severe and refractory major depression. Am J Psychiatry 156: 2017
35. Tejedor-Real P, Mico J A, Maldonado R, Roques B P, Gibert-Rahola J (1995) Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 52: 145-152
36. Valverde O, Mico J A, Maldonado R, Mellado M, Gibert-Rahola J (1994) Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice. Prog Neuropsychopharmacol Biol Psychiatry 18: 1073-1092
37. Waddell A B, Holtzman S G (1998) Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists. Behav Pharmacol 9: 397-407
38. Wang Q P, Nakai Y (1994) The dorsal raphe: an important nucleus in pain modulation. Brain Res Bull 34: 575-585
39. Willner P (1990) Animal models of depression: an overview. Pharmacol Ther 45: 425-455